ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On January 19, 2021, Alterola Biotech, Inc. (the "Company") entered into an
Stock Transfer Agreement (the "Agreement") with ABTI Pharma Limited, a company
registered in England and Wales ("ABTI Pharma"), pursuant to which the Company
will acquire all of the outstanding shares of capital stock of ABTI Pharma from
its shareholders in exchange for 600,000,000 shares of the Company pro rata to
the ABT Pharma shareholders.
On May 24, 2021, the Company and the shareholders of ABTI Pharma memorialized a
new closing date in an amendment to the Agreement (the "Amendment"). We have
already issued the 600,000,000 shares in anticipation of the closing and the
transaction will close upon the ABTI Pharma shares being transferred to the
Company, which will occur upon the filing of the Company's December 31, 2020
quarterly report on Form 10-Q with the Securities and Exchange Commission.
The foregoing description of the Amendment is a summary, does not purport to be
complete, and is qualified in its entirety by reference to the full text of the
Amendment, a copy of which is attached as Exhibit 2.1 to this Current Report on
Form 8-K and incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
2.1 Amendment to Stock Transfer Agreement, dated May 24, 2021
© Edgar Online, source Glimpses